Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas

Acta Neuropathologica
Takao WatanabeHiroko Ohgaki

Abstract

Oligodendrogliomas typically show loss of heterozygosity (LOH) on chromosomes 1p and 19q, which correlates with their response to chemotherapy, whereas low-grade astrocytomas are characterized by frequent TP53 mutations and lack of sensitivity to alkylating therapeutic agents. Unequivocal histological distinction of low-grade diffuse astrocytomas from oligodendrogliomas and oligoastrocytomas is often difficult. To elucidate the relationships between morphological phenotype and genetic profile, we screened 19 oligodendrogliomas (WHO grade II) and 23 low-grade diffuse astrocytomas (WHO grade II) for TP53 mutations and LOH on 1p and 19q. In oligodendrogliomas, LOH on chromosomes 1p and/or 19q was found in 15 cases (79%) and TP53 mutation was detected in 4 cases (21%). The presence of a typical perinuclear halo in >50% of tumour cells and a chicken-wire vascular pattern were significantly associated with LOH on 1p or 19q (93% of cases). This suggests that oligodendrogliomas with classical histologic features are likely to have a better prognosis. In low-grade diffuse astrocytomas, LOH on chromosomes 1p and/or 19q was found in three cases (13%) and TP53 mutation was detected in ten cases (43%). Histologically, five low-grade astrocy...Continue Reading

Citations

Oct 13, 2006·Acta Neuropathologica·Mingqi QuZhi-Ping Ren
Mar 29, 2011·Brain Tumor Pathology·Hiroko Ohgaki, Paul Kleihues
Dec 17, 2008·Current Oncology Reports·Douglas E Ney, Andrew B Lassman
Jul 10, 2003·Lancet Neurology·Peter H WesselsAlbert Twijnstra
Apr 19, 2007·Journal of the National Cancer Institute·Teri-T B NgoJohn K Park
Apr 23, 2010·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Takanori HiroseShio Shimada
Nov 3, 2011·Science Signaling·Nam Hee KimStephen J Weiss
Mar 7, 2012·Journal of Translational Medicine·Annette Bentsen HåvikGuro Elisabeth Lind
Mar 1, 2007·Neuro-oncology·Mitsutoshi NakamuraNoboru Konishi
Jul 21, 2004·Clinical Chemistry and Laboratory Medicine : CCLM·Christian BeetzStephan Patt
Feb 5, 2013·Neurosurgical Focus·Nicholas F Marko, Robert J Weil
Aug 24, 2004·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Christian HartmannAndreas von Deimling
Dec 2, 2014·Neurosurgical Focus·Sameer AgnihotriGelareh Zadeh
Jun 25, 2003·Radiology·Samira GuccioneMark D Bednarski
Sep 30, 2004·International Journal of Cancer. Journal International Du Cancer·Maria MöllemannGuido Reifenberger
Dec 27, 2011·Annals of Diagnostic Pathology·Adriana OlarGregory N Fuller
Nov 9, 2010·NeuroImage·Pramod V ButteLaura Marcu
Jul 14, 2010·Experimental and Molecular Pathology·S SharmaJ K Cowell
Apr 9, 2015·Journal of Neuropathology and Experimental Neurology·Gerald F ReisArie Perry
Sep 6, 2014·Journal of Neuropathology and Experimental Neurology·Takashi OhtaHiroko Ohgaki
Oct 30, 2007·Neurologic Clinics·Martin J van den Bent
Nov 6, 2008·Histopathology·D ScheieK Beiske
Dec 29, 2006·Annals of Neurology·Sibille EverhardJoëlle Thillet
Dec 7, 2010·Brain Pathology·Andreas von DeimlingChristian Hartmann
Apr 14, 2012·Brain Pathology·Maria ThomEleonora Aronica
Aug 3, 2010·Archives of Oral Biology·Dor Mohammad Kordi-TamandaniAdam Torkamanzehi
Feb 15, 2008·Critical Reviews in Oncology/hematology·Martin J Van den BentCharles Vecht
Jun 9, 2004·Annales de génétique·Violaine BourdonPhilippe Jonveaux
May 7, 2015·Neuropathology and Applied Neurobiology·Sebastian Brandner, Andreas von Deimling
Nov 16, 2010·The American Journal of Pathology·Young-Ho KimHiroko Ohgaki
Mar 17, 2012·Cell Cycle·Yong Hoon ChaJong In Yook

❮ Previous
Next ❯

Related Concepts

Related Feeds

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.